DLBCL shows high expression of the monocarboxylate transporter 1 (MCT1), which acts as a crucial controller of glucose metabolism, thereby stimulating the proliferation of DLBCL tumors both in laboratory settings and within living organisms. The gene discussed is SLC16A1; the disease is diffuse large B-cell lymphoma.